CS235976B2 - Method of pyrimidine derivatives production - Google Patents

Method of pyrimidine derivatives production Download PDF

Info

Publication number
CS235976B2
CS235976B2 CS829474A CS947482A CS235976B2 CS 235976 B2 CS235976 B2 CS 235976B2 CS 829474 A CS829474 A CS 829474A CS 947482 A CS947482 A CS 947482A CS 235976 B2 CS235976 B2 CS 235976B2
Authority
CS
Czechoslovakia
Prior art keywords
group
methyl
ethyl
alkyl
pyridyl
Prior art date
Application number
CS829474A
Other languages
Czech (cs)
English (en)
Inventor
Richard P Pioch
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CS235976B2 publication Critical patent/CS235976B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Liquid Crystal Substances (AREA)
CS829474A 1981-12-28 1982-12-21 Method of pyrimidine derivatives production CS235976B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33478481A 1981-12-28 1981-12-28

Publications (1)

Publication Number Publication Date
CS235976B2 true CS235976B2 (en) 1985-05-15

Family

ID=23308823

Family Applications (1)

Application Number Title Priority Date Filing Date
CS829474A CS235976B2 (en) 1981-12-28 1982-12-21 Method of pyrimidine derivatives production

Country Status (23)

Country Link
EP (1) EP0083186B1 (xx)
JP (1) JPS58118585A (xx)
KR (1) KR860000106B1 (xx)
AT (1) ATE34173T1 (xx)
AU (1) AU558153B2 (xx)
CA (1) CA1206151A (xx)
CS (1) CS235976B2 (xx)
DD (1) DD203720A5 (xx)
DE (1) DE3278473D1 (xx)
DK (1) DK574782A (xx)
ES (1) ES518592A0 (xx)
FI (1) FI824407L (xx)
GB (1) GB2111995B (xx)
GR (1) GR78415B (xx)
HU (1) HU192951B (xx)
IE (1) IE54313B1 (xx)
IL (1) IL67496A (xx)
NZ (1) NZ202797A (xx)
PH (1) PH19797A (xx)
PL (1) PL239796A1 (xx)
PT (1) PT76004B (xx)
SU (1) SU1195906A3 (xx)
ZA (1) ZA829247B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468399A (en) * 1981-12-28 1984-08-28 Eli Lilly And Company 2-[2-(2-Aminoalkyl-4-thiazolylmethylthio)alkyl]-amino-5-substituted-4-pyrimidones
GB8320505D0 (en) * 1983-07-29 1983-09-01 Smith Kline French Lab Chemical compounds
US4772704A (en) * 1983-09-21 1988-09-20 Bristol-Myers Company 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
CN102260254A (zh) * 2010-05-31 2011-11-30 中国农业科学院植物保护研究所 新颖2-硝基亚氨基嘧啶衍生物的合成

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
IN146736B (xx) * 1975-10-02 1979-08-25 Smith Kline French Lab
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
AU531142B2 (en) * 1979-04-04 1983-08-11 Smith Kline & French Laboratories Limited 2 amino- pyimindones
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Also Published As

Publication number Publication date
ZA829247B (en) 1984-07-25
AU9153982A (en) 1983-07-07
PT76004B (en) 1985-12-03
DD203720A5 (de) 1983-11-02
NZ202797A (en) 1985-08-30
KR840002831A (ko) 1984-07-21
DK574782A (da) 1983-06-29
KR860000106B1 (ko) 1986-02-19
GR78415B (xx) 1984-09-27
IL67496A (en) 1986-11-30
FI824407A0 (fi) 1982-12-21
PL239796A1 (en) 1984-05-21
EP0083186A3 (en) 1984-05-23
ES8403895A1 (es) 1984-04-01
DE3278473D1 (en) 1988-06-16
CA1206151A (en) 1986-06-17
IE54313B1 (en) 1989-08-16
GB2111995B (en) 1985-07-24
JPS58118585A (ja) 1983-07-14
FI824407L (fi) 1983-06-29
SU1195906A3 (ru) 1985-11-30
PH19797A (en) 1986-07-02
EP0083186B1 (en) 1988-05-11
AU558153B2 (en) 1987-01-22
ES518592A0 (es) 1984-04-01
HU192951B (en) 1987-08-28
GB2111995A (en) 1983-07-13
ATE34173T1 (de) 1988-05-15
IE823031L (en) 1983-06-28
EP0083186A2 (en) 1983-07-06
PT76004A (en) 1983-01-01

Similar Documents

Publication Publication Date Title
DE60311820T2 (de) Neue verwendung von pyrimidin- oder triazin-2-carbonsäurenitrilen zur behandlung von krankheiten, die mit cysteinproteaseaktivität assoziiert sind, und neue pyridimidin-2-carbonsäurenitrilderivate
KR850001795B1 (ko) 2,4-이치환된 티아졸 유도체의 제조방법
EP1442024B1 (en) AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS
DE60118704T2 (de) Pyrimidin-derivate als selective inhibitoren von cox-2
CS200545B2 (en) Method of producing derivatives of guanidine
DD201901A5 (de) Verfahren zur herstellung neuer derivate von 4-amino-6,7-dimethoxy-2-piperazinochinazolin
KR20040048920A (ko) 글리코겐 신타아제 키나제 3-베타 저해제(gsk저해제)로서의 헤테로아릴 아민
SI9520084A (en) Use of heterocyclic compounds as dopamines-d3 ligands
HU211968A9 (en) Heterocyclic amines useful in the therapy of asthma and inflammation of the respiratory tract
DE69724098T2 (de) Chinolin- und benzimidazolderivate als bradykinin agonisten
NO841168L (no) Fremgangsmaate for fremstilling av pyrimidinderivater
SI9520083A (en) Triazole compounds and their use as dopamine-d3-ligands
AU2001259691B2 (en) Modulators of TNF-alpha signaling
DE2658267A1 (de) Pyrimid-4-on- und -thion-derivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
AU2001259691A1 (en) Modulators of TNF-alpha signaling
EP0196005A1 (de) Pyridazinone, ihre Herstellung und diese Verbindungen enthaltende Arzneimittel
PT77855B (en) Pyridine derivatives
NZ207914A (en) Indeno-pyridazinones and pharmaceutical compositions
US3169966A (en) Aminopyrazoles
CS235976B2 (en) Method of pyrimidine derivatives production
DD202552A5 (de) Heterocyclische derivate
EP3737683A1 (en) Inhibitors of low molecular weight protein tyrosine phosphatase (lmptp) and uses thereof
CA3176142A1 (en) Phd inhibitor compounds, compositions, and use
US4468399A (en) 2-[2-(2-Aminoalkyl-4-thiazolylmethylthio)alkyl]-amino-5-substituted-4-pyrimidones
DE60304596T2 (de) In 3-position heterocyclisch substituierte pyridoindolonderivate, ihre herstellung und ihre therapeutische verwendung